Forty percent of patients with chronic rhinosinusitis (CRS) also have asthma, which places them in the subgroup of CRS patients resistant to all types of therapy. Functional endoscopic sinus surgery (FESS) has markedly improved as a treatment for CRS, but its effect on asthma is unclear. Sun Yat-Sen University conducted a study where it evaluated the long-term effect of FESS-oriented multimodal treatment for this subgroup.
Research & Publications
- A Revolutionary Daytime Breakthrough to Treat Sleep Apnea
- Why Do I Have Bad Breath?
- Hearing Loss and Blood Sugar Linked to Mental Decline in Certain Ethnicities
- Immunizations and Vaccinations Explained
- COVID-19 Vaccines: What You Need to Know
- Is Vaping Safe?
- CNN Interview with Dr. Marta Becker: Loss of Smell Drives COVID Survivors to Get Creative in the Kitchen
- Home Remedies for Dry Mouth (Xerostomia)